Kadant Inc. (NYSE:KAI) shares increased 0.97% in last trading session and ended the day at $36.61. KAI Gross Margin is 46.60% and its has a return on assets of 8.00%. Kadant Inc. (NYSE:KAI) quarterly performance is -8.06%.
Zacks Investment Research upgraded shares of Kadant Inc. (NYSE:KAI) from a sell rating to a hold rating in a report published on Tuesday morning, MarketBeat reports.
Saga Communications, Inc. (NYSEMKT:SGA) ended the last trading day at $39.45. Company weekly volatility is calculated as 4.78% and price to cash ratio as 12.13. Saga Communications, Inc. (NYSEMKT:SGA) showed a weekly performance of 4.61%.
On 14 January, Hub Group Inc. (NASDAQ:HUBG) shares increased 0.20% and was closed at $29.52. HUBG EPS growth in last 5 year was 9.00%. Hub Group Inc. (NASDAQ:HUBG) year to date (YTD) performance is -10.41%.
Hub Group, Inc. (NASDAQ:HUBG) will hold a conference call at 5:00 p.m. Eastern Time on Wednesday, February 3, 2016 to discuss its fourth quarter and full year 2015 results. The results will be announced via press release prior to the call on February 3, after the market closes.
Spark Therapeutics, Inc. (NASDAQ:ONCE) shares increased 5.36% in last trading session and ended the day at $32.26. ONCE has a return on assets of -25.30%. Spark Therapeutics, Inc. (NASDAQ:ONCE) quarterly performance is -36.62%.
Spark Therapeutics Inc. (NASDAQ:ONCE) outlined a comprehensive three-year vision for expanding the company’s portfolio through 2018 and launching its first commercial product in 2017, during a presentation this afternoon at the J.P. Morgan 34th Annual Healthcare Conference in San Francisco. Spark Co-founder and Chief Executive Officer, Jeffrey D. Marrazzo, outlined plans for advancing 10 total programs across three therapeutic franchises by 2018, including one commercially approved therapy, two product candidates in pivotal-stage trials and at least seven additional programs in clinical proof-of-concept trials. The company’s 2018 vision for its portfolio is fully funded with existing financial resources, Marrazzo said.
Intrexon Corporation (NYSE:XON) caters to the Healthcare space. It has a net profit margin of -20.20% and weekly performance is -7.30%. On the last day of trading company shares ended up at $25.16. Intrexon Corporation (NYSE:XON) distance from 50-day simple moving average (SMA50) is -23.86%.
Intrexon Corporation (NYSE:XON), announced that Samuel Broder, M.D., Senior Vice President and Head of Intrexon’s Health Sector, presented at the 34th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13th, at 8:30 a.m. Pacific Standard Time at the Westin St. Francis in San Francisco. Chairman and Chief Executive Officer Randal J. Kirk and Chief Operating Officer Krish Krishnan participated in the conference.
Leave a Reply